Events, Publication

Alchemab presents at AD/PD, the International Conference on Alzheimer’s and Parkinson’s Diseases

Ralph Minter, Ph.D. presented “Resilience-Associated CD33 Antibody ATLX-1088, A Potent Stimulator of Microglial Phagocytosis” at AD/PD 2024, the International Conference on Alzheimer’s and Parkinson’s Diseases held 6th March 2024.

@media (min-width:1042px){ #menu-primary-nav .sub-menu{ transition:transform 233ms 610ms, opacity 89ms calc(233ms + 610ms - 89ms) linear; } } @media (max-width:1041px){ #primary-navigation .menu-primary-nav-container{ -webkit-transition: -webkit-transform .233s ease-out, opacity .233s linear; transition: transform .233s ease-out, opacity .233s linear; } }